Kymera Therapeutics, Inc. Common Stock (KYMR) Ownership & Trading Activity
Institutional holders, insider transactions, and congressional trades for KYMR. 13F holdings as of 2026-06-30.
Top Institutional Holders
| Institution | Shares | Value | Change |
|---|---|---|---|
| BlackRock | 5,538,210 | $635M | INCREASED |
| State Street | 2,737,226 | $314M | INCREASED |
| Merck & Co | 772,165 | $89M | UNCHANGED |
| Jennison Associates | 502,978 | $58M | DECREASED |
| Pictet Asset Management Holding | 395,540 | $45M | DECREASED |
Recent Insider Trades
| Insider | Type | Shares | Value | Date |
|---|---|---|---|---|
| Terence Rooney (Chief Medical Officer) | AWARD | 76,000 | $8M | 2026-07-27 |
| Terence Rooney (Chief Medical Officer) | AWARD | 38,000 | 2026-07-27 | |
| Nello Mainolfi (Chief Executive Officer) | EXERCISE | 4,441 | $9K | 2026-07-07 |
| Nello Mainolfi (Chief Executive Officer) | EXERCISE | 45,559 | $95K | 2026-07-07 |
| Nello Mainolfi (Chief Executive Officer) | EXERCISE | 50,000 | $104K | 2026-07-07 |
Full institutional holdings, insider history, and congressional trades for Kymera Therapeutics, Inc. Common Stock on SentiSense.